DigestRedComo funciona
Digest/ Comunicado

RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA +12.5%, ADJUSTED NET INCOME +8.4%. PEAK YEAR SALES TARGETS RAISED FOR KEY RARE DISEASES PRODUCTS

Compatibilidad
Ahorrar(0)
Compartir
RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA +12.5%, ADJUSTED NET INCOME +8.4%. PEAK YEAR SALES TARGETS RAISED FOR KEY RARE DISEASES PRODUCTS
Materiales adjuntos (1)

216_150251_2025_oneinfo.pdf

Descargar kit de prensa ->
Detalles de contacto

Comunicados relacionados

13/02/2025
Biotecnología
Publicidad/Marketing/Medios de comunicación/Comunicación
Anuncios breves
RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA(1) +12.5%, ADJUSTED NET INCOME(2) +8.4% PEAK YEAR SALES TARGETS RAISED FOR KEY RARE DISEASES PRODUCTS
Fuente
RECORDATI
Editor
GLOBENEWSWIRE
Descubre afinidades
0
17/02/2026
Finanzas
Ahorro/Finanzas personales
Fondos de inversión
Industria
RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA +14.5%, ADJUSTED NET INCOME +14.5%
Fuente
RECORDATI
Editor
1INFO
Descubre afinidades
0
17/02/2026
Farmacéutica
Medicina Salud Bienestar
RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA(1) +14.5%, ADJUSTED NET INCOME(2) +14.5%
Fuente
RECORDATI
Editor
GLOBENEWSWIRE
Descubre afinidades
0